Multiplex genome engineering using CRISPR/Cas systems
| [0141]
|
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
| [0141]
|
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
| [0141]
|
Optical control of mammalian endogenous transcription and epigenetic states
| [0141]
|
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
| [0141]
|
DNA targeting specificity of RNA-guided Cas9 nucleases
| [0141]
|
Genome engineering using the CRISPR-Cas9 system
| [0141]
|
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
| [0141]
|
Crystal structure of cas9 in complex with guide RNA and target DNA
| [0141]
|
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
| [0141]
|
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
| [0141]
|
Development and Applications of CRISPR-Cas9 for Genome Engineering
| [0141]
|
Genetic screens in human cells using the CRISPR/Cas9 system
| [0141]
|
Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation
| [0141]
|
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
| [0141]
|
Genome-scale transcription activation by an engineered CRISPR-Cas9 complex
| [0141]
[0141]
|
A split-Cas9 architecture for inducible genome editing and transcription modulation
| [0141]
[0141]
|
Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
| [0141]
[0141]
|
In vivo genome editing using Staphylococcus aureus Cas9
| [0141]
[0141]
|
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
| [0141]
|
Nature
| [0143]
|
PLoS Comput Biol
| [0143]
|
Prot Sci
| [0143]
|
Genetics
| [0186]
[0198]
|
REMINGTON'S PHARMACEUTICAL SCIENCES
| [0189]
[0495]
|
FEBS Let.
| [0194]
|
Nat. Biotech.
| [0194]
|
Mol. Vision.
| [0194]
|
J. Mol. Biol.
| [0194]
|
Nat. Gen.
| [0194]
|
NAR
| [0194]
|
Retina
| [0194]
|
Lipid-like nanoparticles for small interfering RNA delivery to endothelial cells
| [0196]
[0324]
|
Lipid-based nanotherapeutics for siRNA delivery
| [0196]
|
Exosome-mediated delivery of siRNA in vitro and in vivo
| [0196]
[0324]
|
HUMAN GENE THERAPY
| [0196]
|
HUMAN GENE THERAPY
| [0196]
|
J. Virol.
| [0208]
|
J Gene Med
| [0212]
|
HUMAN GENE THERAPY
| [0212]
|
Sci Transl Med
| [0213]
|
In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles
| [0221]
|
ACSNano
| [0222]
|
Mol Pharm
| [0222]
|
J Contr Rel
| [0222]
|
Mol Pharm
| [0222]
|
Mol Pharm
| [0222]
|
J Biophotonics
| [0222]
|
J Raman Spect
| [0222]
|
J Royal Soc Interface
| [0222]
|
Expert Opin Drug Deliv
| [0222]
|
Biomacromolecules
| [0222]
|
Int J Pharm
| [0222]
|
Proc Natl Acad Sci USA.
| [0223]
|
Adv Mater.
| [0223]
|
Nano Lett.
| [0223]
|
ACS Nano
| [0223]
|
ACS Nano
| [0223]
|
Nat Nanotechnol.
| [0223]
|
N Engl J Med
| [0228]
|
Cancer Discovery
| [0229]
|
Molecular Therapy
| [0230]
[0230]
[0231]
[0232]
|
J. Am. Chem. Soc.
| [0234]
|
Small
| [0234]
|
ACS Nano
| [0234]
|
J. Am. Chem. Soc.
| [0234]
|
Nano Lett.
| [0234]
|
Proc. Natl. Acad. Sci. USA.
| [0234]
|
Nanomedicine
| [0234]
|
J. Am. Chem. Soc.
| [0234]
|
Nature
| [0234]
|
Proc. Natl. Acad. Sci. USA.
| [0234]
|
Sci. Transl. Med.
| [0234]
|
Small
| [0234]
|
Nucleic Acids Research
| [0235]
|
PNAS
| [0236]
|
Nature
| [0237]
|
Nature Nanotechnology
| [0248]
[0252]
|
Nat Biotechnol
| [0254]
|
Nature Protocols
| [0259]
|
Nucleic Acids Research
| [0260]
|
Journal of Drug Delivery
| [0262]
[0263]
[0264]
[0265]
|
Nature Biotechnology
| [0267]
|
Nature Letters
| [0267]
[0267]
|
Gene Therapy
| [0268]
|
Lancet
| [0269]
|
J. Clin. Invest.
| [0270]
|
Advanced Drug Delivery Reviews
| [0271]
|
Nature Niotechnology
| [0274]
|
Angew. Chem. Int. Ed.
| [0275]
|
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
| [0276]
|
Molecular Therapy-Nucleic Acids
| [0277]
|
ACS Nano
| [0280]
|
J Pharm Sci.
| [0280]
|
J Control Release
| [0280]
|
Journal of the American Chemical Society
| [0283]
|
Nat. Biotech.
| [0284]
|
Proc. Natl. Acad. Sci. USA
| [0284]
[0286]
|
ACS Chemical Biology
| [0286]
|
Chemistry & Biology
| [0286]
|
Methods in Enzymology
| [0286]
|
Chemistry & Biology
| [0286]
|
Nature
| [0307]
|
Nature Biotech
| [0318]
|
Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology
| [0323]
|
Global non-viral gene transfer to the primate brain following intravenous administration
| [0324]
|
Lipid-based nanotherapeutics for siRNA delivery
| [0324]
|
Rationally engineered therapeutic proteins with reduced immunogenicity
| [0330]
[0495]
|
Overview of principles of hybridization and the strategy of nucleic acid probe assay
| [0345]
|
Nucleic Acids Research
| [0352]
|
NUCLEIC ACIDS RESEARCH
| [0352]
|
J. Mol. Biol.
| [0352]
|
J. MOL. BIOL.
| [0352]
|
Nuc. Acids Research
| [0356]
|
Short Protocols in Molecular Biology
| [0356]
|
J. Mol. Biol.
| [0356]
|
Short Protocols in Molecular Biology
| [0356]
|
FEMS Microbiol Lett.
| [0356]
|
FEMS Microbiol Lett.
| [0356]
|
Gene
| [0358]
|
Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation
| [0359]
|
The classification of amino acid conservation
| [0359]
|
PNAS
| [0361]
|
Trends Biotechnol.
| [0361]
|
MOLECULAR CLONING: A LABORATORY MANUAL
| [0362]
|
CURRENT PROTOCOLS IN MOLECULAR BIOLOGY
| [0362]
|
A PRACTICAL APPROACH
| [0362]
|
ANTIBODIES, A LABORATORY MANUAL
| [0362]
|
ANIMAL CELL CULTURE
| [0362]
|
GENE EXPRESSION TECHNOLOGY: METHODS IN ENZYMOLOGY
| [0367]
[0368]
|
Cell
| [0367]
|
Mol. Cell. Biol.
| [0367]
|
Proc. Natl. Acad. Sci. USA.
| [0367]
|
Gene
| [0369]
|
Gene
| [0370]
|
GENE EXPRESSION TECHNOLOGY: METHODS IN ENZYMOLOGY
| [0370]
|
EMBO J.
| [0371]
|
Cell
| [0371]
|
Gene
| [0371]
|
Mol. Cell. Biol.
| [0372]
|
Virology
| [0372]
|
Nature
| [0373]
|
EMBO J.
| [0373]
|
MOLECULAR CLONING: A LABORATORY MANUAL
| [0373]
|
Genes Dev.
| [0374]
|
Adv. Immunol.
| [0374]
|
EMBO J.
| [0374]
|
Cell
| [0374]
|
Cell
| [0374]
|
Proc. Natl. Acad. Sci. USA
| [0374]
|
Science
| [0374]
|
Science
| [0374]
|
Genes Dev.
| [0374]
|
J. Bacteriol.
| [0375]
|
J. Bacteriol.
| [0375]
|
Mol. Microbiol.
| [0375]
|
Emerg. Infect. Dis.
| [0375]
|
Biochim. Biophys. Acta
| [0375]
|
Mol. Microbiol.
| [0375]
|
OMICS J. Integ. Biol.
| [0375]
|
Mol. Microbiol.
| [0375]
|
J. Bacteriol.
| [0375]
|
Mol. Microbiol.
| [0375]
|
The CRISPR system: small RNA-guided defence in bacteria and archaea
| [0382]
|
Codon Usage Database
| [0385]
|
Codon usage tabulated from the international DNA sequence databases: status for the year 2000
| [0385]
|
Nucleic Acids Res.
| [0392]
|
Cell
| [0392]
|
Nature Biotechnology
| [0392]
|
Science
| [0397]
|
TIBTECH
| [0397]
|
TIBTECH
| [0397]
|
TIBTECH
| [0397]
|
Nature
| [0397]
|
Biotechnology
| [0397]
|
Restorative Neurology and Neuroscience
| [0397]
|
British Medical Bulletin
| [0397]
|
Current Topics in Microbiology and Immunology
| [0397]
|
Gene Therapy
| [0397]
|
Science
| [0397]
|
Cancer Gene Ther.
| [0397]
|
Bioconjugate Chem.
| [0397]
|
Bioconjugate Chem.
| [0397]
|
Gene Therapy
| [0397]
|
Cancer Res.
| [0397]
|
J. Virol.
| [0397]
|
J. Virol.
| [0397]
|
Virol.
| [0397]
|
J. Virol.
| [0397]
|
J. Virol.
| [0397]
|
Virology
| [0397]
|
Human Gene Therapy
| [0397]
|
J. Clin. Invest.
| [0397]
|
Mol. Cell. Biol.
| [0397]
|
Mol. Cell. Biol.
| [0397]
|
PNAS
| [0397]
|
J. Virol.
| [0397]
|
Plant genome editing made easy: targeted mutagenesis in model and crop plants using the CRISPR/Cas system
| [0400]
|
Efficient gene editing in tomato in the first generation using the CRISPR/Cas9 system
| [0400]
|
Targeted genome modification of crop plants using a CRISPR-Cas system
| [0400]
|
Efficient genome editing in plants using a CRISPR/Cas system
| [0400]
|
RNA-guided genome editing in plants using a CRISPR-Cas system
| [0400]
|
Gene targeting using the Agrobacterium tumefaciens-mediated CRISPR-Cas system in rice
| [0400]
|
Exploiting SNPs for biallelic CRISPR mutations in the outcrossing woody perennial Populus reveals 4-coumarate: CoA ligase specificity and Redundancy
| [0400]
|
Targeted DNA degradation using a CRISPR device stably carried in the host genome
| [0400]
|
Crop genomics: advances and applications
| [0400]
|
Clinical Immunology
| [0440]
|
Genetic Instabilities and Neurological Diseases
| [0450]
|
RNA Biol.
| [0450]
|
Genetics of Epilepsy and Genetic Epilepsies
| [0451]
|
Genetic Diseases of the Eye
| [0452]
|
Genetic Disorders
| [0453]
|
Genetic Brain Disorders
| [0453]
|
Crop genomics:advances and applications
| [0475]
|
A TALEN genome-editing system for generating human stem cell-based disease models
| [0495]
|
Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations
| [0495]
|
Efficient TALEN-mediated gene knockout in livestock
| [0495]
|
Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases
| [0495]
|
Targeted mutagenesis in the silkworm Bombyx mori using zinc finger nuclease mRNA injection
| [0495]
|
Non-transgenic genome modifications in a hemimetabolous insect using zinc-finger and TAL effector nucleases
| [0495]
|
Chimeric nucleases stimulate gene targeting in human cells
| [0495]
|
An improved zinc-finger nuclease architecture for highly specific genome editing
| [0495]
|
Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA)
| [0495]
|
Targeted genome editing across species using ZFNs and TALENs
| [0495]
|
Targeting DNA double-strand breaks with TAL effector nucleases
| [0495]
[0495]
|
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription
| [0495]
|
A TALE nuclease architecture for efficient genome editing
| [0495]
|
FLASH assembly of TALENs for high-throughput genome editing
| [0495]
|
Breaking the code of DNA binding specificity of TAL-type III effectors
| [0495]
|
A simple cipher governs DNA recognition by TAL effectors
| [0495]
|
A transcription activator-like effector toolbox for genome engineering
| [0495]
|
CRISPR-Cas system and its role in phage-bacteria interactions
| [0495]
|
CRISPR-Cas, the immune system of bacteria and archaea
| [0495]
|
Evolution and classification of the CRISPR-Cas systems
| [0495]
|
CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation
| [0495]
|
Multiplex genome engineering using CRISPR-Cas systems
| [0495]
|
RNA-guided human genome engineering via Cas9
| [0495]
|
RNA-programmed genome editing in human cells
| [0495]
|
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
| [0495]
|
The CRISPR-Cas bacterial immune system cleaves bacteriophage and plasmid DNA
| [0495]
|
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity
| [0495]
|
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
| [0495]
|
Genome editing with engineered zinc finger nucleases
| [0495]
|
Dissecting neural function using targeted genome engineering technologies
| [0495]
|
Establishment of HIV-1 resistance in CD4(+) T cells by genome editing using zinc-finger nucleases
| [0495]
|
Multiplex Genome Engineering Using CRISPR-Cas Systems
| [0495]
|
High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases
| [0495]
|
In vivo genome editing using a high-efficiency TALEN system
| [0495]
|
Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells
| [0495]
|
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
| [0495]
[0495]
|
The Streptococcus thermophilus CRISPR-Cas system provides immunity in Escherichia coli
| [0495]
|
Efficient genome editing in zebrafish using a CRISPR-Cas system
| [0495]
|
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR-Cas-Mediated Genome Engineering
| [0495]
|
Generation of gene-modified mice via Cas9/RNA-mediated gene targeting
| [0495]
|
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression
| [0495]
|
Expanding small RNA interference
| [0495]
|
Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination
| [0495]
|
High frequency targeting of genes to specific sites in the mammalian genome
| [0495]
|
The length of homology required for gene targeting in embryonic stem cells
| [0495]
|
A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond
| [0495]
|
A rapid and general assay for monitoring endogenous gene modification
| [0495]
|
Translocation capture sequencing: a method for high throughput mapping of chromosomal rearrangements
| [0495]
|
Nucleotide sequences in Xenopus 5S DNA required for transcription termination
| [0495]
|
Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers
| [0495]
|
Overcoming transcription activator-like effector (TALE) DNA binding domain sensitivity to cytosine methylation
| [0495]
|
A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
| [0495]
|
Targeted genome editing in pluripotent stem cells using zinc-finger nucleases
| [0495]
|
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
| [0495]
|
Die kinetik der invertinwirkung
| [0495]
|
De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks
| [0495]
|
Probable inference, the law of succession, and statistical inference
| [0495]
|
Retinal gene therapy with a large MYO7A cDNA using adeno-assocaited virus
| [0495]
|
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial
| [0495]
|
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B
| [0495]
|
Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors
| [0495]
|
Two alternative promoters direct neuron-specific expression of the rat microtubule-associated protein 1B gene
| [0495]
|
Definition of an efficient synthetic poly(A) site
| [0495]
|
Production and titering of recombinant adeno-associated viral vectors
| [0495]
|
Developments in neuronal cell culture
| [0495]
|
Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos
| [0495]
|
Mammalian base excision repair: the forgotten archangel
| [0495]
|
Heritable genome editing in C. elegans via a CRISPR-Cas9 system
| [0495]
|
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
| [0495]
|
Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease
| [0495]
|
DNA targeting specificity of RNA-guided Cas9 nucleases
| [0495]
|
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
| [0495]
|
Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining
| [0495]
|
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
| [0495]
|
CRISPR provides acquired resistance against viruses in prokaryotes
| [0495]
|
CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity
| [0495]
|
Xanthomonas AvrBs3 family-type III effectors: discovery and function
| [0495]
|
Classification and evolution of type II CRISPR-Cas systems
| [0495]
|
Multiplex genome engineering using CRISPR/Cas systems
| [0495]
|
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
| [0495]
|
Mammalian base excision repair: the forgotten archangel
| [0495]
|
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
| [0495]
|
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
| [0495]
|
Molecular mechanisms of CRISPR-mediated microbial immunity
| [0495]
|
Development and Applications of CRISPR-Cas9 for Genome Engineering
| [0495]
|
DNA targeting specificity of RNA-guided Cas9 nucleases
| [0495]
|
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity
| [0495]
|
The discovery of zinc fingers and their applications in gene regulation and genome manipulation
| [0495]
|
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
| [0495]
|
CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
| [0495]
|
Short motif sequences determine the targets of the prokaryotic CRISPR defence system
| [0495]
|
Crystal structure of cas9 in complex with guide RNA and target DNA
| [0495]
|
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
| [0495]
|
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
| [0495]
|
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering
| [0495]
|
RNA-guided genetic silencing systems in bacteria and archaea
| [0495]
|
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
| [0495]
|
In vivo genome editing using Staphylococcus aureus Cas9
| [0495]
|